Leelyn Smith LLC increased its position in CME Group Inc. (NASDAQ:CME – Free Report) by 4.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,259 shares of the financial services provider’s stock after acquiring an additional 480 shares during the quarter. Leelyn Smith LLC’s holdings in CME Group were worth $2,484,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. grew its stake in shares of CME Group by 0.6% in the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after acquiring an additional 45 shares during the last quarter. CVA Family Office LLC raised its position in shares of CME Group by 11.8% during the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after buying an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich raised its position in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares during the last quarter. Zions Bancorporation N.A. increased its stake in CME Group by 3.7% during the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after acquiring an additional 54 shares during the period. Finally, Quent Capital LLC raised its holdings in CME Group by 10.2% in the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.
CME Group Stock Performance
CME stock opened at $229.04 on Friday. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.74. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a market cap of $82.54 billion, a PE ratio of 24.08, a P/E/G ratio of 5.23 and a beta of 0.55. The business’s 50-day moving average price is $223.64 and its two-hundred day moving average price is $211.07.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is currently 48.37%.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on CME shares. Deutsche Bank Aktiengesellschaft dropped their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a research report on Thursday, October 24th. Piper Sandler lifted their price objective on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Morgan Stanley upped their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Finally, TD Cowen began coverage on shares of CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 price target for the company. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $224.47.
Get Our Latest Research Report on CME Group
Insiders Place Their Bets
In other news, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the sale, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This represents a 15.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. The trade was a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 in the last quarter. 0.30% of the stock is currently owned by insiders.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- 3 Monster Growth Stocks to Buy Now
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Transportation Stocks Investing
- MarketBeat Week in Review – 11/18 – 11/22
- What is MarketRank™? How to Use it
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.